Experienced in Angiosarcoma of the Liver

Shigenori Kadowaki

Nagoya, JP 
Experienced in Angiosarcoma of the Liver
Nagoya, JP 
OverviewLocationsClinical Research

Overview

Shigenori Kadowaki practices in Nagoya, Japan. Kadowaki is rated as an Experienced expert by MediFind in the treatment of Angiosarcoma of the Liver. Their top areas of expertise are Stomach Cancer, Esophageal Cancer, Ascites, Endoscopy, and Tissue Biopsy.

Their clinical research consists of co-authoring 136 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Angiosarcoma of the Liver.

Locations

Nagoya, 4648681, Japan
Other Locations
Okazaki, Japan
Tokyo, Japan
Saitama, 3620806, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter, Randomized, Open-label, Phase 3 Trial Comparing Selpercatinib to Physicians Choice of Cabozantinib or Vandetanib in Patients With Progressive, Advanced, Kinase Inhibitor Naïve, RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)
A Multicenter, Randomized, Open-label, Phase 3 Trial Comparing Selpercatinib to Physicians Choice of Cabozantinib or Vandetanib in Patients With Progressive, Advanced, Kinase Inhibitor Naïve, RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Selpercatinib, Cabozantinib, Vandetanib
Study Phase: Phase 3

136 Total Publications

Relationship between programmed cell death ligand 1 expression and the number of biopsy specimens in advanced gastric cancer.
Relationship between programmed cell death ligand 1 expression and the number of biopsy specimens in advanced gastric cancer.
Journal: Journal of cancer research and clinical oncology
Published: June 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kadowaki's expertise for a condition
ConditionClose
View All 12 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile